Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

366 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:42 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Late-Start Corifollitropin Alfa in Mild Ovarian Stimulation

ClinicalTrials.gov · NCT07891793 · Registry updated: 2026-10-23

Condition / research focus: Infertile Patient Undergoing ICSI Procedure
Sponsor: Assisting Nature
Countries with listed sites: Greece
Registry dates and results: Start: 2024-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Corifollitropin Alfa 150 μg (drug) — also listed as: Elonva 150μg
GnRH antagonist (drug)
Progesterone (drug)
Human Menopausal Gonadotropin (hMG) (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Assisting Nature Fertility Clinic
Thessaloniki, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3Not yet recruitingINTERVENTIONAL

Verapamil In Preclinical Type 1 Diabetes

ClinicalTrials.gov · NCT07880769 · Registry updated: 2026-10-22

Condition / research focus: Type 1 Diabetes
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2027-01. Completion: 2031-03 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Verapamil 120 Mg/24 Hours Oral Capsule, Extended Release (drug)
Placebo (other)
blood sampling (biological)
EKG and cardiological evaluation (other)
Continuous Glucose Monitoring (CGM) (other)
Urine collection (other)

Where the study takes place — 1 listed sites

Hôpital Robert Debré
Paris, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

LE + CC vs. LE for Ovulation Induction

ClinicalTrials.gov · NCT06934785 · Registry updated: 2026-10-20

Condition / research focus: Letrozole; Clomiphene Citrate; Ovulation Disorder; Ovulation Induction
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2025-04-28. Completion: 2027-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IUI or intercourse (procedure)

Where the study takes place — 1 listed sites

My Duc Hospital
Ho Chi Minh City, Ho Chi Minh City, Vietnam
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1Not yet recruitingINTERVENTIONAL

hCG Treatment for Rehabilitation From a TBI

ClinicalTrials.gov · NCT07557615 · Registry updated: 2026-10-19

Condition / research focus: Traumatic Brain Injury
Sponsor: VA Office of Research and Development
Countries with listed sites: United States
Registry dates and results: Start: 2027-01-01. Completion: 2029-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ovidrel (drug) — also listed as: Choriogonadotropin alfa
Placebo (other)

Where the study takes place — 1 listed sites

William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Machine-Learning Prediction of Pregnancy Outcomes After Assisted Reproductive Treatments

ClinicalTrials.gov · NCT07855783 · Registry updated: 2026-10-07

Condition / research focus: IVF Outcomes; Prediction Models; Infertility Assisted Reproductive Technology; Live Birth
Sponsor: BetaPlus Center for Reproductive Medicine
Countries with listed sites: Croatia
Registry dates and results: Start: 2026-01-01. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Machine-Learning Model for Prediction of Pregnancy Outcomes (other)

Where the study takes place — 2 listed sites

Clinical Hospital Center
Rijeka, Croatia
Site recruitment: Recruiting
BetaPlus Center for Reproductive Medicine
Zagreb, Croatia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders

ClinicalTrials.gov · NCT07861399 · Registry updated: 2026-10-06

Condition / research focus: ICSI; IVF; Normal Responders; Infertility Assisted Reproductive Technology; Infertile Women Undergoing IVF or ICSI; Infertile Women Undergoing ART; Triggering Ovulation; Oocyte Maturation
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2026-09-01. Completion: 2028-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dual trigger (human chorionic gonadotropin plus GnRH-agonist) (drug) — also listed as: Triptorelin acetate and human chorionic gonadotropin
hCG trigger (drug) — also listed as: human chorionic gonadotropin

Where the study takes place — 1 listed sites

ART Unit, International Islamic Center for Population Studies and Research, Al-Azhar University
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles

ClinicalTrials.gov · NCT07425990 · Registry updated: 2026-09-29

Condition / research focus: Infertility Female; Frozen Embryo Transfer (FET)
Sponsor: University of Novi Sad
Countries with listed sites: Serbia
Registry dates and results: Start: 2026-03-13. Completion: 2027-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (Aromatase Inhibitors) (drug)
Choriogonadotropin alpha (r-hCG) (drug)
Progesterone (drug)

Where the study takes place — 1 listed sites

Specialized Gynecological Hospital "Ferona" Novi Sad
Novi Sad, Serbia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders

ClinicalTrials.gov · NCT07824102 · Registry updated: 2026-09-17

Condition / research focus: Osteoporosis; Hypercalcemia; Primary Hyperparathyroidism; Adrenal Gland Disease; Pituitary Disease; Thyroid Diseases
Sponsor: Martin Blomberg Jensen
Countries with listed sites: Denmark
Registry dates and results: Start: 2026-01-01. Completion: 2045-12 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Department of Endocrinology and Internal Medicine, Herlev Hospital
Herlev, Denmark
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females

ClinicalTrials.gov · NCT06418347 · Registry updated: 2026-09-16

Condition / research focus: Polycystic Ovary Syndrome; Infertility, Female
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-04-01. Completion: 2025-08-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Alpha lipoic acid (drug) — also listed as: ALA
Letrozole (drug)

Where the study takes place — 1 listed sites

Ain shams university
Cairo, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)

ClinicalTrials.gov · NCT07816562 · Registry updated: 2026-09-11

Condition / research focus: Low Ovarian Reserve; Poor Ovarian Response
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Countries with listed sites: Spain
Registry dates and results: Start: 2024-09-17. Completion: 2028-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotropin (hCG) (drug) — also listed as: hCG
Follitropin delta (drug)
Triptorelin (drug)

Where the study takes place — 1 listed sites

Hospital Clínico Universitario de Valencia
Valencia, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableEnrolling by invitationINTERVENTIONAL

Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating Its Equivalence to Standard Controlled Ovarian Stimulation Protocols in Terms of Oocytes Retrieved, Blastulation While Maintaining an Economic Advantage

ClinicalTrials.gov · NCT07771283 · Registry updated: 2026-08-27

Condition / research focus: Infertility (IVF Patients); Infertility Assisted Reproductive Technology; Infertile Patients; Infertility Drugs; Infertile Women Undergoing IVF or ICSI; Infertility; Stimulation in the Ovary; Infertile Women Undergoing ART; Controlled Ovarian Simulation; Infertile Women Undergoing Assisted Reproductive Technology (ART)
Sponsor: LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro
Countries with listed sites: Uganda · Ukraine
Registry dates and results: Start: 2026-08-17. Completion: 2028-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Chorionic Gonadotropin (hCG) (drug)
GnRH antagonist (drug)
Dual trigger (human chorionic gonadotropin plus GnRH-agonist) (drug) — also listed as: GnRH-agonist in case high risk of OHSS
Gonadotropins (FSH or FSH/LH) (drug)
Gonadotropins (FSH or FSH/LH) (drug)

Where the study takes place — 3 listed sites

Sali international school of fertility medicine
Kampala, Uganda
Site recruitment: Not reported
LTD "Yuzko" Yuzko Medical Center
Chernivtsi, Ukraine
Site recruitment: Not reported
LTD "EKODNIPRO" Medical Centre "Medical Plaza"
Dnipro, Ukraine
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intra-Ovarian PRP Compared With Gonadotropin for Ovarian Response in Letrozole-Resistant PCOS

ClinicalTrials.gov · NCT07777640 · Registry updated: 2026-08-20

Condition / research focus: Polycystic Ovary Syndrome (PCOS)
Sponsor: Bangladesh Medical University
Countries with listed sites: Bangladesh
Registry dates and results: Start: 2025-06-01. Completion: 2026-05-28 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Autologous Platelet-Rich Plasma (PRP) (biological)
Gonadotropin (drug)

Where the study takes place — 1 listed sites

Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University
Dhaka, Dhaka Division, Bangladesh
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Association Between Peri-Transfer Endometrial Peristalsis And Live Birth In Modified Natural Cycle Frozen Embryo Transfer: A Prospective Cohort Study

ClinicalTrials.gov · NCT07358468 · Registry updated: 2026-08-19

Condition / research focus: Infertility; Endometrial Peristalsis; Uterine Contraction; Endometrial Waves; Frozen Embryo Transfer (FET); Uterine Peristalsis
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2026-02-22. Completion: 2027-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Endometrial peristalsis and hormone measurements (other)

Where the study takes place — 2 listed sites

My Duc Phu Nhuan Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Recruiting
IVFMD Phu Nhuan - My Duc Phu Nhuan Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not yet recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.

ClinicalTrials.gov · NCT06659692 · Registry updated: 2026-07-16

Condition / research focus: Ovarian Stimulation; Infertility
Sponsor: IBSA Institut Biochimique SA
Countries with listed sites: Canada
Registry dates and results: Start: 2024-09-23. Completion: 2025-08-29 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropins Subcutaneous (drug)

Where the study takes place — 2 listed sites

Pharma Medica Research Inc.
Toronto, Ontario, Canada
Site recruitment: Not reported
Syneos Health
Québec, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.

ClinicalTrials.gov · NCT05473273 · Registry updated: 2026-06-25

Condition / research focus: Infertility, Female
Sponsor: ART Fertility Clinics LLC
Countries with listed sites: United Arab Emirates
Registry dates and results: Start: 2023-04-24. Completion: 2026-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Endometrin 100Mg Vaginal Insert (drug)
Estradiol Valerate (drug)

Where the study takes place — 1 listed sites

ART Fertility Clinics LLC
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Corpus Luteum Function and Cardiovascular Adaptation in a Natural MOCK Cycle.

ClinicalTrials.gov · NCT07648381 · Registry updated: 2026-06-15

Condition / research focus: Menstrual Cycle; Luteal Phase Progesterone Levels; Luteal Phase Adaptation; MOCK Cycle
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2026-07-01. Completion: 2028-09 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood samples for the analysis of biomarkers. (diagnostic_test)
Transvaginal ultrasound for follicle and endometrium measurements. (diagnostic_test)
Mean Arterial Pressure measurement. (diagnostic_test)
Ovitrelle injection for ovulation induction (drug)

Where the study takes place — 1 listed sites

UZ Brussel
Jette, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Extended Letrozole Protocol Versus Letrozole Plus Inositol for Induction of Ovulation in Letrozole Resistant PCOS Women

ClinicalTrials.gov · NCT07635082 · Registry updated: 2026-06-09

Condition / research focus: Polycystic Ovary Syndrome (PCOS) Women; Polycystic Ovary Syndrome
Sponsor: Eman Basuni Ebrahim Mowad
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-02-01. Completion: 2025-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ELP (Extended Letrozole Protocol) (drug)
LIP (Letrozole + Inositol Protocol) (drug)

Where the study takes place — 1 listed sites

Kafrelsheikh University Hospital
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

The Application of HCG in Luteal Support for Frozen Embryo Transfer in Ovulation Cycle of Obese Women

ClinicalTrials.gov · NCT07633002 · Registry updated: 2026-06-08

Condition / research focus: Obesity, Maternal
Sponsor: The Second Hospital of Shandong University
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-07-01. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Chorionic Gonadotropin (drug) — also listed as: HCG

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Point of Care Tests in the Management of Very Early Medical Abortion

ClinicalTrials.gov · NCT07417787 · Registry updated: 2026-06-03

Condition / research focus: Abortion Early
Sponsor: University of Edinburgh
Countries with listed sites: Sweden · United Kingdom
Registry dates and results: Start: 2026-04-23. Completion: 2028-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood test (diagnostic_test)
Participant Questionnaire (other)

Where the study takes place — 3 listed sites

University of Gothenberg
Gothenburg, Sweden
Site recruitment: Not yet recruiting
Karolinska Institutet
Stockholm, Sweden
Site recruitment: Not yet recruiting
Chalmers Sexual Health Clinic
Edinburgh, United Kingdom
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of Dydrogesterone Alone Versus Dydrogesterone Plus HCG in Threatened Miscarriage

ClinicalTrials.gov · NCT07608133 · Registry updated: 2026-05-27

Condition / research focus: Threatened Miscarriage; Early Pregnancy Bleeding
Sponsor: Pakistan Air Force (PAF) Hospital Islamabad
Countries with listed sites: Pakistan
Registry dates and results: Start: 2025-12-09. Completion: 2026-05-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dydrogesterone (drug)
Human chorionic gonadotrophin (hCG) (drug)

Where the study takes place — 1 listed sites

Pakistan Air Force Hospital, Islamabad
Islamabad, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

366 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:42 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Late-Start Corifollitropin Alfa in Mild Ovarian Stimulation

ClinicalTrials.gov · NCT07891793 · Registry updated: 2026-10-23

Condition / research focus: Infertile Patient Undergoing ICSI Procedure
Sponsor: Assisting Nature
Countries with listed sites: Greece
Registry dates and results: Start: 2024-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Corifollitropin Alfa 150 μg (drug) — also listed as: Elonva 150μg
GnRH antagonist (drug)
Progesterone (drug)
Human Menopausal Gonadotropin (hMG) (drug)

Where the study takes place — 1 listed sites

Assisting Nature Fertility Clinic
Thessaloniki, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3Not yet recruitingINTERVENTIONAL

Verapamil In Preclinical Type 1 Diabetes

ClinicalTrials.gov · NCT07880769 · Registry updated: 2026-10-22

Condition / research focus: Type 1 Diabetes
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2027-01. Completion: 2031-03 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Verapamil 120 Mg/24 Hours Oral Capsule, Extended Release (drug)
Placebo (other)
blood sampling (biological)
EKG and cardiological evaluation (other)
Continuous Glucose Monitoring (CGM) (other)
Urine collection (other)

Where the study takes place — 1 listed sites

Hôpital Robert Debré
Paris, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

LE + CC vs. LE for Ovulation Induction

ClinicalTrials.gov · NCT06934785 · Registry updated: 2026-10-20

Condition / research focus: Letrozole; Clomiphene Citrate; Ovulation Disorder; Ovulation Induction
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2025-04-28. Completion: 2027-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IUI or intercourse (procedure)

Where the study takes place — 1 listed sites

My Duc Hospital
Ho Chi Minh City, Ho Chi Minh City, Vietnam
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1Not yet recruitingINTERVENTIONAL

hCG Treatment for Rehabilitation From a TBI

ClinicalTrials.gov · NCT07557615 · Registry updated: 2026-10-19

Condition / research focus: Traumatic Brain Injury
Sponsor: VA Office of Research and Development
Countries with listed sites: United States
Registry dates and results: Start: 2027-01-01. Completion: 2029-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ovidrel (drug) — also listed as: Choriogonadotropin alfa
Placebo (other)

Where the study takes place — 1 listed sites

William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Machine-Learning Prediction of Pregnancy Outcomes After Assisted Reproductive Treatments

ClinicalTrials.gov · NCT07855783 · Registry updated: 2026-10-07

Condition / research focus: IVF Outcomes; Prediction Models; Infertility Assisted Reproductive Technology; Live Birth
Sponsor: BetaPlus Center for Reproductive Medicine
Countries with listed sites: Croatia
Registry dates and results: Start: 2026-01-01. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Machine-Learning Model for Prediction of Pregnancy Outcomes (other)

Where the study takes place — 2 listed sites

Clinical Hospital Center
Rijeka, Croatia
Site recruitment: Recruiting
BetaPlus Center for Reproductive Medicine
Zagreb, Croatia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders

ClinicalTrials.gov · NCT07861399 · Registry updated: 2026-10-06

Condition / research focus: ICSI; IVF; Normal Responders; Infertility Assisted Reproductive Technology; Infertile Women Undergoing IVF or ICSI; Infertile Women Undergoing ART; Triggering Ovulation; Oocyte Maturation
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2026-09-01. Completion: 2028-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dual trigger (human chorionic gonadotropin plus GnRH-agonist) (drug) — also listed as: Triptorelin acetate and human chorionic gonadotropin
hCG trigger (drug) — also listed as: human chorionic gonadotropin

Where the study takes place — 1 listed sites

ART Unit, International Islamic Center for Population Studies and Research, Al-Azhar University
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles

ClinicalTrials.gov · NCT07425990 · Registry updated: 2026-09-29

Condition / research focus: Infertility Female; Frozen Embryo Transfer (FET)
Sponsor: University of Novi Sad
Countries with listed sites: Serbia
Registry dates and results: Start: 2026-03-13. Completion: 2027-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (Aromatase Inhibitors) (drug)
Choriogonadotropin alpha (r-hCG) (drug)
Progesterone (drug)

Where the study takes place — 1 listed sites

Specialized Gynecological Hospital "Ferona" Novi Sad
Novi Sad, Serbia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders

ClinicalTrials.gov · NCT07824102 · Registry updated: 2026-09-17

Condition / research focus: Osteoporosis; Hypercalcemia; Primary Hyperparathyroidism; Adrenal Gland Disease; Pituitary Disease; Thyroid Diseases
Sponsor: Martin Blomberg Jensen
Countries with listed sites: Denmark
Registry dates and results: Start: 2026-01-01. Completion: 2045-12 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Department of Endocrinology and Internal Medicine, Herlev Hospital
Herlev, Denmark
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females

ClinicalTrials.gov · NCT06418347 · Registry updated: 2026-09-16

Condition / research focus: Polycystic Ovary Syndrome; Infertility, Female
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-04-01. Completion: 2025-08-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Alpha lipoic acid (drug) — also listed as: ALA
Letrozole (drug)

Where the study takes place — 1 listed sites

Ain shams university
Cairo, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)

ClinicalTrials.gov · NCT07816562 · Registry updated: 2026-09-11

Condition / research focus: Low Ovarian Reserve; Poor Ovarian Response
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Countries with listed sites: Spain
Registry dates and results: Start: 2024-09-17. Completion: 2028-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotropin (hCG) (drug) — also listed as: hCG
Follitropin delta (drug)
Triptorelin (drug)

Where the study takes place — 1 listed sites

Hospital Clínico Universitario de Valencia
Valencia, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableEnrolling by invitationINTERVENTIONAL

Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating Its Equivalence to Standard Controlled Ovarian Stimulation Protocols in Terms of Oocytes Retrieved, Blastulation While Maintaining an Economic Advantage

ClinicalTrials.gov · NCT07771283 · Registry updated: 2026-08-27

Condition / research focus: Infertility (IVF Patients); Infertility Assisted Reproductive Technology; Infertile Patients; Infertility Drugs; Infertile Women Undergoing IVF or ICSI; Infertility; Stimulation in the Ovary; Infertile Women Undergoing ART; Controlled Ovarian Simulation; Infertile Women Undergoing Assisted Reproductive Technology (ART)
Sponsor: LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro
Countries with listed sites: Uganda · Ukraine
Registry dates and results: Start: 2026-08-17. Completion: 2028-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Chorionic Gonadotropin (hCG) (drug)
GnRH antagonist (drug)
Dual trigger (human chorionic gonadotropin plus GnRH-agonist) (drug) — also listed as: GnRH-agonist in case high risk of OHSS
Gonadotropins (FSH or FSH/LH) (drug)
Gonadotropins (FSH or FSH/LH) (drug)

Where the study takes place — 3 listed sites

Sali international school of fertility medicine
Kampala, Uganda
Site recruitment: Not reported
LTD "Yuzko" Yuzko Medical Center
Chernivtsi, Ukraine
Site recruitment: Not reported
LTD "EKODNIPRO" Medical Centre "Medical Plaza"
Dnipro, Ukraine
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intra-Ovarian PRP Compared With Gonadotropin for Ovarian Response in Letrozole-Resistant PCOS

ClinicalTrials.gov · NCT07777640 · Registry updated: 2026-08-20

Condition / research focus: Polycystic Ovary Syndrome (PCOS)
Sponsor: Bangladesh Medical University
Countries with listed sites: Bangladesh
Registry dates and results: Start: 2025-06-01. Completion: 2026-05-28 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Autologous Platelet-Rich Plasma (PRP) (biological)
Gonadotropin (drug)

Where the study takes place — 1 listed sites

Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University
Dhaka, Dhaka Division, Bangladesh
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Association Between Peri-Transfer Endometrial Peristalsis And Live Birth In Modified Natural Cycle Frozen Embryo Transfer: A Prospective Cohort Study

ClinicalTrials.gov · NCT07358468 · Registry updated: 2026-08-19

Condition / research focus: Infertility; Endometrial Peristalsis; Uterine Contraction; Endometrial Waves; Frozen Embryo Transfer (FET); Uterine Peristalsis
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2026-02-22. Completion: 2027-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Endometrial peristalsis and hormone measurements (other)

Where the study takes place — 2 listed sites

My Duc Phu Nhuan Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Recruiting
IVFMD Phu Nhuan - My Duc Phu Nhuan Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not yet recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.

ClinicalTrials.gov · NCT06659692 · Registry updated: 2026-07-16

Condition / research focus: Ovarian Stimulation; Infertility
Sponsor: IBSA Institut Biochimique SA
Countries with listed sites: Canada
Registry dates and results: Start: 2024-09-23. Completion: 2025-08-29 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropins Subcutaneous (drug)

Where the study takes place — 2 listed sites

Pharma Medica Research Inc.
Toronto, Ontario, Canada
Site recruitment: Not reported
Syneos Health
Québec, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.

ClinicalTrials.gov · NCT05473273 · Registry updated: 2026-06-25

Condition / research focus: Infertility, Female
Sponsor: ART Fertility Clinics LLC
Countries with listed sites: United Arab Emirates
Registry dates and results: Start: 2023-04-24. Completion: 2026-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Endometrin 100Mg Vaginal Insert (drug)
Estradiol Valerate (drug)

Where the study takes place — 1 listed sites

ART Fertility Clinics LLC
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Corpus Luteum Function and Cardiovascular Adaptation in a Natural MOCK Cycle.

ClinicalTrials.gov · NCT07648381 · Registry updated: 2026-06-15

Condition / research focus: Menstrual Cycle; Luteal Phase Progesterone Levels; Luteal Phase Adaptation; MOCK Cycle
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2026-07-01. Completion: 2028-09 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood samples for the analysis of biomarkers. (diagnostic_test)
Transvaginal ultrasound for follicle and endometrium measurements. (diagnostic_test)
Mean Arterial Pressure measurement. (diagnostic_test)
Ovitrelle injection for ovulation induction (drug)

Where the study takes place — 1 listed sites

UZ Brussel
Jette, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Extended Letrozole Protocol Versus Letrozole Plus Inositol for Induction of Ovulation in Letrozole Resistant PCOS Women

ClinicalTrials.gov · NCT07635082 · Registry updated: 2026-06-09

Condition / research focus: Polycystic Ovary Syndrome (PCOS) Women; Polycystic Ovary Syndrome
Sponsor: Eman Basuni Ebrahim Mowad
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-02-01. Completion: 2025-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ELP (Extended Letrozole Protocol) (drug)
LIP (Letrozole + Inositol Protocol) (drug)

Where the study takes place — 1 listed sites

Kafrelsheikh University Hospital
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

The Application of HCG in Luteal Support for Frozen Embryo Transfer in Ovulation Cycle of Obese Women

ClinicalTrials.gov · NCT07633002 · Registry updated: 2026-06-08

Condition / research focus: Obesity, Maternal
Sponsor: The Second Hospital of Shandong University
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-07-01. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Chorionic Gonadotropin (drug) — also listed as: HCG

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Point of Care Tests in the Management of Very Early Medical Abortion

ClinicalTrials.gov · NCT07417787 · Registry updated: 2026-06-03

Condition / research focus: Abortion Early
Sponsor: University of Edinburgh
Countries with listed sites: Sweden · United Kingdom
Registry dates and results: Start: 2026-04-23. Completion: 2028-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood test (diagnostic_test)
Participant Questionnaire (other)

Where the study takes place — 3 listed sites

University of Gothenberg
Gothenburg, Sweden
Site recruitment: Not yet recruiting
Karolinska Institutet
Stockholm, Sweden
Site recruitment: Not yet recruiting
Chalmers Sexual Health Clinic
Edinburgh, United Kingdom
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of Dydrogesterone Alone Versus Dydrogesterone Plus HCG in Threatened Miscarriage

ClinicalTrials.gov · NCT07608133 · Registry updated: 2026-05-27

Condition / research focus: Threatened Miscarriage; Early Pregnancy Bleeding
Sponsor: Pakistan Air Force (PAF) Hospital Islamabad
Countries with listed sites: Pakistan
Registry dates and results: Start: 2025-12-09. Completion: 2026-05-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dydrogesterone (drug)
Human chorionic gonadotrophin (hCG) (drug)

Where the study takes place — 1 listed sites

Pakistan Air Force Hospital, Islamabad
Islamabad, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →